Ipratropium Bromide: Clinical Trials

5 trials of Ipratropium Bromide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 unknown. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Not yet recruiting 1, Unknown 1

Follow Ipratropium Bromide: new trials by email Literature Review of Ipratropium Bromide trials Research Report on Ipratropium Bromide

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of Ipratropium Bromide on EILO
Ipratropium Bromide, Normal Saline (Placebo) - Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity
Phase 2Not yet recruitingCook Children's Health Care System502026-06-012026-05-05
Treating Respiratory Emergencies in Children Study
Ipratropium Bromide - Asthma in Children
Phase 2CompletedOregon Health and Science University442024-01-192026-04-24
Revefenacin in Acute Respiratory Insufficiency in COPD
Revefenacin Inhalation Solution [Yupelri], Ipratropium Bromide - COPD, Acute Respiratory Failure
Phase 2CompletedUniversity of California, Los Angeles212020-11-012026-10-14
Ipratropium Bromide Spray as Treatment for Sialorrhea in Children
Ipratropium bromide, Placebo - Sialorrhea
Phase 2UnknownLondon Health Sciences Centre302019-01-012018-11-21
Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study
EP-101 via nebulizer (eFlow®) 25 ug, EP-101 via nebulizer (eFlow®) 50 ug, EP-101 via nebulizer (eFlow®) 100 ug - Chronic Obstructive Pulmonary Disease
Phase 2CompletedSunovion Respiratory Development Inc.1402011-08-012018-05-09

Conditions studied

Pulmonary Disease, Chronic Obstructive (2)  ·  Sialorrhea (1)

Sponsors

Cook Children's Health Care System (1)  ·  London Health Sciences Centre (1)  ·  Oregon Health and Science University (1)  ·  Sunovion Respiratory Development Inc. (1)  ·  University of California, Los Angeles (1)

Countries

United States (4)  ·  United Kingdom (1)

Top investigators

Ahmet Tutuncu, M.D., Ph.D. (1)  ·  Donald Tashkin, MD (1)  ·  Igor Z Barjaktarevic, MD, PhD (1)  ·  Julie Strychowsky, MD (1)  ·  Matthew L Hansen, MD, MCR (1)

Results publications

PMID 41943480